June's AI-picked stock updates now live. See what's new in Tech Titans, up 28.5% year to date.Unlock Stocks

Biotech ETF Powering Higher

Published 06/07/2021, 02:59 PM
Updated 07/09/2023, 06:31 AM
VRTX
-
GILD
-
IBB
-
AMGN
-
BIIB
-
ILMN
-
MRNA
-

IBB Daily Chart.

The biotech sector is on fire as the new week begins. The iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) is posting its best gain of 2021 on extremely heavy volume. This powerful move is driving the ETF past the March/April highs on what is already heaviest upside trade since Nov. 4, 2020.

Details: Despite trading at new three-month highs the IBB is far from overbought (daily MACD=neutral). There is plenty of room to run.

The IBB has been trading inside a five-day range (March 1-5). This narrow sideways action is giving way with an upside breakout.

The Top 5 XBI holdings: Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Moderna (NASDAQ:MRNA), Illumina (NASDAQ:ILMN) and Vertex Pharmaceuticals (NASDAQ:VRTX).

Related news: Biogen (NASDAQ:BIIB) Drug Gets FDA Approval for Alzheimer’s Treatment By Investing.com

Investment Objective: The iShares Nasdaq Biotechnology ETF seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ.

Note: We are long GILD and ILMN in some managed accounts.

You can read Gary S. Morrow's original post here.

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.